FDB Launches AI-Native Medication Workflow Protocol for Healthcare
Event summary
- FDB launched MedProof MCP™, an AI-native Model Context Protocol server for medication workflows, on March 31, 2026.
- The protocol enables safe, agentic workflows informed by trusted medication intelligence at scale.
- Artera, serving over 100 million patients, is an early adopter of FDB MedProof MCP.
- FDB plans to launch FDB Script Agent™, an AI-enabled prescription automation solution, next.
The big picture
FDB's launch of MedProof MCP marks a shift from data delivery to AI-native infrastructure in healthcare, addressing the growing demand for safe and reliable AI-driven medication decision support. The protocol's integration with major EHRs and its adoption by Artera highlight its potential to transform patient communications and prescription automation. This move positions FDB as a key player in defining how AI safely integrates into medication decision-making.
What we're watching
- Adoption Pace
- How quickly healthcare organizations and developers will integrate FDB MedProof MCP into their workflows.
- Competitive Response
- Whether competitors will develop similar AI-native protocols for medication workflows.
- Regulatory Compliance
- The extent to which FDB MedProof MCP will meet evolving regulatory standards for AI in healthcare.
Related topics